Dr. Robert Shmerling http://wrvo.org en Fibromyalgia -- what is known and unknown http://wrvo.org/post/fibromyalgia-what-known-and-unknown <p>Imagine being in a large amount of pain and not knowing the cause. Or, having a disorder that’s not recognized by a significant amount of medical professionals. This cloud of uncertainty hangs over the millions that suffer from fibromyalgia, a disorder with an unknown cause and limited treatments.</p><p>This week on "Take Care," <a href="http://www.bidmc.org/CentersandDepartments/Departments/Medicine/Divisions/Rheumatology/MeetOurTeam/LeadershipTeam.aspx">Dr. Robert Shmerling</a> talks about the controversial disorder known as fibromyalgia. Dr. Shmerling is a Harvard Medical School professor and clinical chief of rheumatology at Beth Israel Deaconess Medical Center in Boston.</p><p><strong>Click 'Read More' to hear our interview with Dr. Shmerling.</strong></p><p> Sun, 27 Apr 2014 23:00:00 +0000 Take Care Staff 54777 at http://wrvo.org Fibromyalgia -- what is known and unknown Osteoarthritis affects millions, but who's most at risk? http://wrvo.org/post/osteoarthritis-affects-millions-whos-most-risk <p>It may be common to have pain and stiffness in your joints -- especially as you age-- but what’s the difference between routine pain and a serious disease? This week on “Take Care,” we talk to <a href="http://robertshmerling.gather.com/">Dr. Robert Shmerling</a> about <a href="http://www.bidmc.org/YourHealth/BIDMCInteractive/HealthyIs/ForFutureUse_DoNotPublishFolder/Osteoarthritis.aspx">osteoarthritis</a>, the most common form of arthritis, which affects millions of people. Shmerling an associate professor in medicine at Harvard Medical School, senior medical editor at Harvard Health Publications and associate physician and clinical chief of rheumatology at the Beth Israel Deaconess Medical Center.</p><p><strong>Click 'Read More' to hear our interview with Dr. Shmerling.</strong></p><p> Sun, 28 Jul 2013 23:01:00 +0000 Take Care Staff 41650 at http://wrvo.org Osteoarthritis affects millions, but who's most at risk?